Skip to main content

What the FDA labels say about taking them together

Cannabidiol and divalproex

Divalproex's FDA label of March 31, 2026 names cannabidiol in its drug interactions section; cannabidiol's label does not name divalproex itself but warns about its class (Anti-seizure medicines).

Check it at the source: the cannabidiol FDA label on DailyMed (effective May 29, 2026, Jazz Pharmaceuticals, Inc.); the divalproex FDA label on DailyMed (effective March 31, 2026, AbbVie Inc.).

What does the cannabidiol label say about divalproex?

Cannabidiol's label does not name divalproex itself; it warns about its class (Anti-seizure medicines):

Cannabidiol label, warnings and precautions

Behavior and Ideation Antiepileptic drugs (AEDs), including EPIDIOLEX, increase the risk of suicidal thoughts or behavior in patients taking these drugs for any indication.

Cannabidiol label, warnings and precautions

Patients treated with an AED for any indication should be monitored for the emergence or worsening of depression, suicidal thoughts or behavior, or any unusual changes in mood or behavior.

Source: FDA drug label (Epidiolex), Jazz Pharmaceuticals, Inc., effective May 29, 2026 (SPL set 8bf27097-4870-43fb-94f0-f3d0871d1eec), via openFDA; the full label on DailyMed

What does the divalproex label say about cannabidiol?

Divalproex label, drug interactions

Hyperammonemia and encephalopathy ( 5.10 , 7.3 ) Cannabidiol: ALT and/or AST elevation

Source: FDA drug label (Depakote), AbbVie Inc., effective March 31, 2026 (SPL set 08a65cf4-7749-4ceb-6895-8f4805e2b01f), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

0Cannabidiol generic labelers
44Divalproex generic labelers
CannabidiolDivalproex
Labeled forn/aBipolar disorder, Migraine, Seizures and epilepsy
Boxed warningNoYes
Pharmacy cost (NADAC)n/a$0.194 per tablet 500 mg tablet
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?